Page last updated: 2024-08-21

alpha-aminopyridine and Fibromatosis, Aggressive

alpha-aminopyridine has been researched along with Fibromatosis, Aggressive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beule, A; Blomqvist, C; Ihalainen, H; Rönty, M; Santti, K; Tarkkanen, M	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Fibromatosis, Aggressive

Article	Year
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report. Acta oncologica (Stockholm, Sweden), 2019, Volume: 58, Issue:6 Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fibromatosis, Aggressive; Goserelin; Humans; Letrozole; Protein Kinase Inhibitors; Purines; Young Adult	2019

Article

Year

The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.

Acta oncologica (Stockholm, Sweden), 2019, Volume: 58, Issue:6

Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fibromatosis, Aggressive; Goserelin; Humans; Letrozole; Protein Kinase Inhibitors; Purines; Young Adult

2019